Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 19/20 | 0.59 |
| ▸ | MMP9 | P14780 | 16/20 | 0.59 |
| ▸ | MMP1 | P03956 | 11/20 | 0.59 |
| ▸ | MMP3 | P08254 | 11/20 | 0.59 |
| ▸ | MMP13 | P45452 | 11/20 | 0.59 |
| ▸ | MMP7 | P09237 | 10/20 | 0.59 |
| ▸ | MMP14 | P50281 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 2/20 | 0.41 |
| ▸ | MMP12 | P39900 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6414527 | 0.89 | MMP2 (0.75) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL7427052 | 0.78 | MMP2 (0.56) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL7425260 | 0.76 | MMP2 (0.72) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL6418173 | 0.74 | MMP2 (0.73) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL29347161 | 0.72 | LMNA (0.51) | ALDH1A1LMNAMMP8 | |
| SCHEMBL12656355 | 0.72 | CA12 (0.57) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL10119353 | 0.69 | LMNA (0.51) | ALDH1A1LMNA | |
| SCHEMBL14191408 | 0.69 | MMP2 (0.74) | MMP2MMP9MMP1MMP3MMP13 | |
| SCHEMBL13186484 | 0.69 | SMN1; SMN2 (0.60) | ALDH1A1LMNA | |
| SCHEMBL6419846 | 0.68 | MMP2 (0.65) | MMP2MMP9MMP1MMP3MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1047450-B1 | ACE INHIBITOR-MMP INHIBITOR COMBINATIONS | WARNER LAMBERT CO (US) | 2002-10-02 | — | — | EP | disclosed |
| EP-1047450-A1 | ACE INHIBITOR-MMP INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 2000-11-02 | — | — | EP | disclosed |
| US-6133304-A | TREATING FIBROSIS, VENTRICULAR DILATION, AND/OR HEART FAILURE IN A MAMMAL BY ADMINISTERING AN ANTIFIBROTIC AMOUNT OF A MIXTURE OF AN ANGIOTENSIN-CONVERTING ENZYME(ACE) INHIBITOR AND AT LEAST ONE MATRIX METALLOPROTEINASE(MMP) INHIBITOR | WARNER-LAMBERT COMPANY (US) | 2000-10-17 | — | — | US | disclosed |
| WO-1999032150-A1 | ACE INHIBITOR-MMP INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |